Paclitaxel-Eluting Coronary Artery Stent - Vietnam Registration 2402200ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Paclitaxel-Eluting Coronary Artery Stent in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2402200ĐKLH/BYT-HTTB and manufactured by Cardionovum GmbH. The authorized representative in Vietnam is CÔNG TY TNHH TRANG THIẾT BỊ Y TẾ M - B VIỆT NAM.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Theo theo phụ lục, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2402200ĐKLH/BYT-HTTB
000.00.04.G18-221229-0019
Theo theo phụ lục
Theo phụ lục
Technical Details
The Paclitaxel-coated stent is indicated for the treatment of patients with symptoms of myocardial ischemia due to atherosclerotic lesions of the coronary arteries with a reference vessel diameter ranging from 1.5 mm to 4.00 mm, to improve the internal diameter of the coronary arteries. The Paclitaxel-coated stent is particularly recommended for the treatment of restenosis of the coronary arteries within the stent and for the treatment of small atherosclerotic lesions of the coronary arteries with a diameter less than 3.00 mm.
Dates and Status
Aug 27, 2024